Knowing Cholesterol Effects on Alzheimerâ€™s Disease

Knowing Cholesterol Effects on Alzheimerâ€™s Disease

No Abstract

Bibliographic Details
Main Author:	Dwi Nur Ahsani
Format:	Article
Language:	English
Published:	Faculty of Medicine 2016-01-01
Series:	JKKI (Jurnal Kedokteran dan Kesehatan Indonesia)
Online Access:	https://journal.uii.ac.id/JKKI/article/view/3680

Similar Items

Nerve Cell Deterioration Associated with Alzheimerâs Disease
by: Yaping Tu
Published: (2010-01-01)

Oxidative stress and the amyloid beta peptide in Alzheimerâs disease
by: C. Cheignon, et al.
Published: (2018-04-01)

Glucocorticoids and stress in Alzheimerâ€™s disease pathology : causality and mechanisms
by: Catania, Caterina
Published: (2007)

Wyzwania terapii otępienia w chorobie Alzheimera
by: Tomasz Gabryelewicz, et al.
Published: (2013-06-01)

Nieprawidłowy stan odżywienia u pacjentów zchorobą Alzheimera
by: Anna Łucka, et al.
Published: (2017-12-01)

Oksydacyjne uszkodzenia DNA w chorobie Alzheimera i Creutzfeldta-Jakoba
by: Sylwia M. Grešner, et al.
Published: (2011-04-01)

Choroba Alzheimera – rola badań immunohistochemicznych w diagnostyce choroby = Alzheimer's disease - the role of immunohistochemistry in the diagnosis of disease
by: Beata Cichacz-Kwiatkowska, et al.
Published: (2016-02-01)

Diabetes Mellitus Type 2 as a Major Risk Factor of Developing Alzheimerâ€™s Disease in Pakistani Population
by: Nelofer Sultana, et al.
Published: (2011-07-01)

Jakość życia chorych na chorobę Alzheimera / The life quality of the people suffering from Alzheimer’s disease
by: Kozak-Putowska Dorota, et al.
Published: (2016-06-01)

Distribution and costs profile of the Specialized Component of the Pharmaceutical Assistance for AlzheimerÂs Disease in the state of CearÃ
by: Francisco JosÃ Oliveira de Pontes
Published: (2015)

Rola VEGF, czynnika neurotroficznego i proangiogennego w patogenezie choroby Alzheimera
by: Marta Nowacka, et al.
Published: (2011-07-01)

Rola wybranych czynników ryzyka w etiopatogenezie i przebiegu choroby Alzheimera
by: Robert Dudkowiak, et al.
Published: (2013-06-01)

A comparison of the cytokine responses of a1-antichymotrypsin (ACT) and angiotensinogen (AGT) and the role of ACT in Alzheimerâ€™s disease
by: Baker, Crystal A.
Published: (2006)

Farmakoterapia dysfunkcji poznawczych w chorobie Alzheimera: obecne strategie i terapie eksperymentalne
by: Tomasz Sobów
Published: (2013-12-01)

Human Ependymin-1 Neurotrophic Factor Mimetics Reduce Tau Phosphorylation and Cellular Apoptosis in Vitro and in Vivo in Alzheimerâ€™s Disease Models
by: Ronayne, Rachel E.
Published: (2008)

Low Serum Vitamin B12 in AlzheimerÃ»s Patients as Detected by a Solid Phase Radioimmunoassay
by: Areechun Sotthibundhu, et al.
Published: (2008-03-01)

Low Serum Vitamin B12 in AlzheimerÃ»s Patients as Detected by a Solid Phase Radioimmunoassay
by: Areechun Sotthibundhu, et al.
Published: (2008-01-01)

Farmakoterapia choroby Alzheimera i innych otępień wpraktyce: który lek, kiedy i dla kogo?
by: Marcin Wojtera, et al.
Published: (2014-12-01)

Skuteczność kliniczna doustnego preparatu Souvenaid® jako wsparcia niefarmakologicznego osób z chorobą Alzheimera – przegląd badań
by: Anna Barczak
Published: (2017-08-01)

Mechanism of Reversal of Alzheimerâ€™s Disease A-beta Induced Neuronal Degeneration in Cultured Human SHSY Cells Using A Neurotrophic Ependymin Mimetic.
by: kapoor, varun
Published: (2007)

MITOKONDRIA SEBAGAI TARGET TERAPI KANKER
by: Dwi Nur Ahsani
Published: (2014-01-01)

RESPON IMUN PADA INFEKSI JAMUR
by: Dwi Nur Ahsani
Published: (2014-06-01)

Wpływ aktywności fizycznej na sprawność funkcji poznawczych osób w podeszłym wieku i na przebieg choroby Alzheimera
by: Tomasz Gabryelewicz, et al.
Published: (2013-04-01)

Rozpad sprawności leksykalnych u pacjenta z otępieniem umiarkowanym w chorobie Alzheimera a możliwości komunikowania się z otoczeniem
by: Aneta Domagała
Published: (2019-12-01)

Helping people with dementia of the Alzheimerâ€™s type find their way around their environment, employing errorless learning, vanishing cues and spaced retrieval methods
by: Arthur, Michelle Lucienne
Published: (2006)

Heart Disease and Diverse Audiences: What You Should Know to Lower Your Fat and Cholesterol
by: Jackson, Ruth, et al.
Published: (2006)

Age-related changes of malondialdehyde, body weight and organ weight in male mice
by: Dwi Nur Ahsani, et al.
Published: (2018-06-01)

Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and Ignore
by: Catherine Juste, et al.
Published: (2021-09-01)

A Summary of Coronavirus Disease 2019: What We Should Know?
by: Ysrafil Ysrafil, et al.
Published: (2020-11-01)

Hepatic cholesterol metabolism in cholesterol gallstone disease
by: E Reihnér, et al.
Published: (1991-03-01)

Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know
by: Mathias Schwartz, et al.
Published: (2019-09-01)

To Know or Not to Know: Ethical Issues Related to Early Diagnosis of Alzheimer's Disease
by: Niklas Mattsson, et al.
Published: (2010-01-01)

What We Know and Do Not Know about Sex and Cardiac Disease
by: John P. Konhilas
Published: (2010-01-01)

Protective effect of ethanolic Feronia elephantum Correa fruit extract on high-fat diet induced steatohepatitis in rats
by: Maruni Wiwin Diarti, et al.
Published: (2021-02-01)

Vitamin D and Kidney disease: what we know and what we do not know
by: Antonio Jose Inda Filho, et al.
Published: (2013-12-01)

Cholesterol, statins, and Alzheimer disease.
by: Alexei R Koudinov, et al.
Published: (2005-03-01)

Cholesterol, Statins, and Alzheimer Disease
by: Berezov Temirbolat T
Published: (2005-01-01)

Effect of cholesterol and cholesterol analogues on platelet function
by: McLeod, Andrew J.
Published: (1981)

THE EFFECTIVENESS OF KNOW-WANT TO KNOW-LEARNED (KWL) STRATEGY IN READING COMPREHENSION
by: author Dian Rakhmawati
Published: (2015-01-01)

THE EFFECTIVENESS OF KNOW-WANT TO KNOW-LEARNED (KWL) STRATEGY IN READING COMPREHENSION
by: author Dian Rakhmawati
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_371aqln2po28vhd7u38aa8a3lg